Deltex Medical Group plc
DEMG.L · LSE
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | £1,064 | £717 | £1,059 | £1,324 |
| % Growth | 48.4% | -32.3% | -20% | – |
| Cost of Goods Sold | £353 | £320 | £351 | £357 |
| Gross Profit | £711 | £397 | £708 | £967 |
| % Margin | 66.8% | 55.4% | 66.9% | 73% |
| R&D Expenses | £84 | £17 | £96 | £91 |
| G&A Expenses | £597 | £439 | £642 | £781 |
| SG&A Expenses | £859 | £697 | £1,158 | £1,293 |
| Sales & Mktg Exp. | £262 | £258 | £427 | £473 |
| Other Operating Expenses | £210 | £318 | £0 | £0 |
| Operating Expenses | £1,153 | £1,032 | £1,254 | £1,384 |
| Operating Income | -£442 | -£635 | -£546 | -£417 |
| % Margin | -41.5% | -88.6% | -51.6% | -31.5% |
| Other Income/Exp. Net | -£104 | -£111 | -£30 | -£108 |
| Pre-Tax Income | -£546 | -£746 | -£576 | -£525 |
| Tax Expense | £0 | -£1 | -£39 | -£42 |
| Net Income | -£546 | -£745 | -£538 | -£483 |
| % Margin | -51.3% | -103.9% | -50.8% | -36.5% |
| EPS | -0 | -0 | -0.001 | -0.001 |
| % Growth | 25% | 50% | -14.3% | – |
| EPS Diluted | -0 | -0 | -0.001 | -0.001 |
| Weighted Avg Shares Out | 1,895,833 | 1,659,243 | 703,801 | 698,987 |
| Weighted Avg Shares Out Dil | 1,891,934 | 1,659,202 | 703,228 | 698,807 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £119 | £108 |
| Interest Expense | £0 | £111 | £119 | £108 |
| Depreciation & Amortization | £39 | £23 | £58 | £72 |
| EBITDA | -£403 | -£655 | -£399 | -£345 |
| % Margin | -37.9% | -91.4% | -37.7% | -26.1% |